Crossmark

Effect of low-level laser therapy (LLLT) on cognitive impairment among patients with chronic schizophrenia: a double-blind randomized placebo-controlled clinical trial

Crossref DOI link: https://doi.org/10.1007/s10103-022-03545-9

Published Online: 2022-03-22

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kheradmand, Ali

Tabeie, Faraj

Seif, Pegah https://orcid.org/0000-0001-7883-9330
Rezaei, Omid

Yasamy, Mohammad Taghi
Funding

Funding for this research was provided by:

shahid beheshti university of medical sciences
License Information

Text and Data Mining valid from 2022-03-22

Version of Record valid from 2022-03-22
More Information

Article History

Received: 19 July 2021

Accepted: 10 March 2022

First Online: 22 March 2022

Declarations

:

: The research was approved by the Ethical Committee of Shahid Beheshti University of Medical Sciences (ethical code: IR.SBMU.MSP. REC.1400.067). The current clinical trial has also been registered in the Iranian Registry of Clinical Trials (IRCT)-IRCT 20210520051349N1.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below